John Hussman's HRMY Position Overview
John Hussman (via Hussman Strategic Advisors, Inc.) currently holds 84,000 shares of Harmony Biosciences Holdings, Inc. (HRMY) worth $2.35 M, representing 0.51% of the portfolio. First purchased in 2023-Q1, this medium-term investment has been held for 13 quarters.
Based on 13F filings, John Hussman has maintained a strategic position in HRMY, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2024, adding 42,000 shares. Largest reduction occurred in Q3 2025, reducing 63,000 shares.
Analysis based on 13F filings available since 2013 Q2
John Hussman's Harmony Biosciences Holdings (HRMY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Harmony Biosciences Holdings (HRMY) Trades by John Hussman
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +21,000 | Add 33.33% | 84,000 | $28.01 |
| Q4 2025 | +21,000 | Add 50.00% | 63,000 | $37.42 |
| Q3 2025 | -63,000 | Reduce 60.00% | 42,000 | $27.56 |
| Q2 2025 | +21,000 | Add 25.00% | 105,000 | $31.60 |
| Q4 2024 | +21,000 | Add 33.33% | 84,000 | $34.41 |
| Q3 2024 | +42,000 | Add 200.00% | 63,000 | $40.00 |
| Q4 2023 | -10,000 | Reduce 32.26% | 21,000 | $32.30 |
| Q1 2023 | +31,000 | New Buy | 31,000 | $32.65 |
John Hussman's Harmony Biosciences Holdings Investment FAQs
John Hussman first purchased Harmony Biosciences Holdings, Inc. (HRMY) in Q1 2023, acquiring 31,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Hussman has held Harmony Biosciences Holdings, Inc. (HRMY) for 13 quarters since Q1 2023.
John Hussman's largest addition to Harmony Biosciences Holdings, Inc. (HRMY) was in Q3 2024, adding 63,000 shares worth $2.52 M.
According to the latest 13F filing for Q1 2026, John Hussman's firm, Hussman Strategic Advisors, Inc., owns 84,000 shares of Harmony Biosciences Holdings, Inc. (HRMY), valued at approximately $2.35 M.
As of the Q1 2026 filing, Harmony Biosciences Holdings, Inc. (HRMY) represents approximately 0.51% of John Hussman's publicly disclosed stock portfolio, making it one of their key holdings.
John Hussman's peak holding in Harmony Biosciences Holdings, Inc. (HRMY) was 105,000 shares, as reported at the end of Q2 2025.